Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis

A manual method for applying the Hansch approach to drug design

John G. Topliss · Journal of Medicinal Chemistry · 1977 · 216 citations · Full text

Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

Karen R. Romines, George A. Freeman, Lee T. Schaller et al. · Journal of Medicinal Chemistry · 2005 · 167 citations

Synthesis of Novel Diarylpyrimidine Analogues and Their Antiviral Activity against Human Immunodeficiency Virus Type 1

Jérôme Guillemont, Élisabeth Pasquier, Patrice Palandjian et al. · Journal of Medicinal Chemistry · 2004 · 117 citations

Their Antiviral Activity, New Diarylpyrimidine, Biochemistry +13

Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase

Martha De la Rosa, Hong Woo Kim, Esmir Gunić et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 109 citations

Tri-substituted Triazoles, Medicine, Hiv-1 Reverse Transcriptase +8

HIV-1 Reverse Transcriptase Plus-strand Initiation Exhibits Preferential Sensitivity to Non-nucleoside Reverse Transcriptase Inhibitors in Vitro

Jay A. Grobler, Geetha Dornadula, Michele R. Rice et al. · Journal of Biological Chemistry · 2006 · 108 citations · Full text